Enclosure (1) to COMDTINST 6010.21A
FY 94 MONITORING AND EVALUATION SCHEDULE
QUARTER
| 1st
| 2nd
| 3rd
| 4th
_____________|__________|___________|_____________|___________
|
|
|
|
INITIAL
| MED-3
| DUR-3
|
DENT-3
| MED-4
_____________|__________|___________|_____________|___________
|
|
|
|
*FOLLOW-UP
| DENT-2
| ADMIN-2 |
MED-3
| DUR-3
_____________|__________|___________|_____________|___________
CLINICAL ASPECTS OF CARE FOR MONITORING AND EVALUATION
MED-1:
Strep Throat
Urinary Tract Infection
MED-2:
Gastroenteritis
Hypertension
MED-3:
Nonspecific Vaginitis
Otitis Externa
DENT-1:
Exodontia Informed Consent
Annual Dental Examinations
Dental Emergencies
DENT-2:
Post-operative Infections
DENT-3:
Biopsies
DUR-1:
NSAID Therapy
Antibiotic Therapy
DUR-2:
Antihistamine Therapy
Antilipemic Therapy
DUR-3:
Intranasal Steroid Therapy
Oral Contraceptive Therapy